Vycor Medical (VYCO) Return on Capital Employed (2011 - 2026)

Vycor Medical (VYCO) has 16 years of Return on Capital Employed data on file, last reported at 2.25% in Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 259.0% year-over-year to 2.25% in Q1 2026; TTM through Mar 2026 was 2.25%, a 259.0% decrease from a year earlier, with the FY2025 full-year figure at 0.88%, down 114.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 2.25%, down from 0.87% in the prior quarter.
• Over the last five years, Return on Capital Employed for VYCO reached as high as 15.61% in Q2 2022 and fell as low as 2.3% in Q3 2025.
• Historically, Return on Capital Employed has averaged 3.51% across 5 years, with a median of 0.34% in 2025.
• Across the five-year window, Return on Capital Employed slumped 2696 bps in 2022 and soared 306 bps in 2024, its largest moves.
• Year by year, Return on Capital Employed stood at 11.15% in 2022, then tumbled by 112 bps to 1.32% in 2023, then soared by 120 bps to 0.26% in 2024, then slumped by 429 bps to 0.87% in 2025, then sank by 159 bps to 2.25% in 2026.
• Per Business Quant data, the three most recent Return on Capital Employed figures were 2.25% in Q1 2026, 0.87% in Q4 2025, and 2.3% in Q3 2025.